XTX Topco Ltd Makes New $479,000 Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

Key Points

• XTX Topco Ltd has acquired a new investment in Surgery Partners, Inc. by purchasing 20,151 shares valued at approximately $479,000.
• Several large institutional investors, including Janus Henderson Group and Point72 Asset Management, made significant increases in their stakes in Surgery Partners during the recent quarter.
• Analysts have a general consensus of a "Moderate Buy" rating for Surgery Partners, with price targets ranging from $24.00 to $35.00, projecting potential growth for the company.

XTX Topco Ltd purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 20,151 shares of the company's stock, valued at approximately $479,000.

Other hedge funds have also bought and sold shares of the company. DekaBank Deutsche Girozentrale purchased a new position in Surgery Partners in the 1st quarter valued at approximately $65,000. State of Wyoming grew its stake in Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after buying an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. grew its stake in Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after buying an additional 465 shares in the last quarter. GAMMA Investing LLC grew its stake in Surgery Partners by 7,902.7% in the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock valued at $211,000 after buying an additional 8,772 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in Surgery Partners by 279.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after buying an additional 7,925 shares in the last quarter.

Surgery Partners Price Performance

Shares of SGRY traded up $0.42 during mid-day trading on Friday, reaching $23.64. 1,704,277 shares of the stock traded hands, compared to its average volume of 1,697,857. The firm has a fifty day moving average price of $22.16 and a 200 day moving average price of $22.97. The company has a market cap of $3.03 billion, a price-to-earnings ratio of -16.53 and a beta of 1.82. The company has a current ratio of 1.93, a quick ratio of 1.73 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 1 year low of $18.87 and a 1 year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $826.20 million during the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.21 EPS. As a group, equities research analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Barclays reduced their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 27th. Bank of America assumed coverage on shares of Surgery Partners in a research note on Monday, July 28th. They issued a "buy" rating and a $28.00 price objective for the company. Finally, Benchmark reiterated a "buy" rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Monday, April 21st. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $33.00.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.